CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression
Luminal B breast cancers (BC) have a more aggressive behavior associated with a higher rate of tumor relapse and worse prognosis compared to luminal A tumors. In this study, we evaluated the involvement of specific epithelial-to-mesenchymal transition- (EMT-) and immune-related pathways in the disse...
Main Authors: | Carlotta Raschioni, Giulia Bottai, Andrea Sagona, Valentina Errico, Alberto Testori, Wolfgang Gatzemeier, Fabio Corsi, Corrado Tinterri, Massimo Roncalli, Libero Santarpia, Luca Di Tommaso |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2018/5018671 |
Similar Items
-
ONE STEP NUCLEIC ACID AMPLIFICATION IN BREAST CANCER SENTINEL LYMPH NODE.A SINGLE INSTITUTIONAL EXPERIENCE AND A SHORT REVIEW.
by: Tatiana eBrambilla, et al.
Published: (2015-06-01) -
Neo-adjuvant chemotherapy in luminal, node positive breast cancer: characteristics, treatment, and oncological outcomes. A single center’s experience
by: E. Barbieri, et al.
Published: (2021-04-01) -
Protumor immunity and breast cancer development
by: Coussens LM
Published: (2009-07-01) -
CXCR7 functions as a scavenger for CXCL12 and CXCL11.
by: Ulrike Naumann, et al.
Published: (2010-02-01) -
CXCL14 antagonizes the CXCL12-CXCR4 signaling axis
by: Hara Takahiko, et al.
Published: (2014-05-01)